Prosperity Bancshares, Inc
Banking
Prosperity Bancshares, Inc (PB) Stock News
The latest PB headlines and market coverage — 5 recent stories, updated throughout the day.
- The Motley Fool·
Consumer Staples ETFs: How PBJ and XLP Stack Up
The article compares two consumer staples ETFs: XLP (State Street Consumer Staples Select Sector SPDR ETF) and PBJ (Invesco Food & Beverage ETF). XLP offers a broader consumer staples exposure with a significantly lower expense ratio (0.08% vs 0.61%), higher dividend yield (2.6% vs 1.6%), and superior 5-year performance ($1,344 vs $1,174 on $1,000 invested). PBJ focuses narrowly on food and beverage stocks with a more concentrated portfolio. Both are defensive investments with low volatility, but XLP emerges as the stronger choice for most investors due to its cost efficiency, higher returns, and larger asset base.
- GlobeNewswire Inc.·
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
Pomerantz LLP is investigating potential securities fraud claims against Prestige Consumer Healthcare Inc. following the company's May 13, 2026 earnings announcement that revealed a 4.5% organic revenue decline and production issues with Clear Eyes products. The stock fell 11.35% to $45.93 per share on May 14, 2026, prompting the investigation into whether company officers and directors engaged in unlawful business practices.
- GlobeNewswire Inc.·
New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
Ipsen announced late-breaking results from the ELATIVE Phase III trial and real-world studies showing IQIRVO (elafibranor) demonstrated clinically meaningful improvements in fatigue, with 67% of patients achieving improvement versus 31% on placebo at Week 52. Real-world data showed 59% of patients achieved ALP normalization at 6 months, and the Phase IV ELFINITY study confirmed rapid ALP reductions and favorable tolerability in routine clinical practice.
- Benzinga·
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
Marpai Inc. announced a historic expansion with 192,000 new estimated member lives across its TPA and MarpaiRx PBM platforms, representing a nearly six-fold increase. The company expects to achieve positive cash flow and positive EBITDA beginning August 2026, with rollouts scheduled between August 2026 and January 2027.
- GlobeNewswire Inc.·
Purpose Built Backup Appliance (PBBA) Market Size to Hit USD 22.0 Billion by 2035 | SNS Insider
The global Purpose Built Backup Appliance (PBBA) market is projected to grow from USD 8.67 billion in 2025 to USD 22.0 billion by 2035, driven by rising ransomware threats, increased enterprise data volumes, and regulatory compliance requirements. The market is experiencing rapid growth across North America and Europe, with Asia Pacific emerging as the fastest-growing region. Hardware components and open systems dominate the market, while services are expected to grow fastest.